Authors: Luca Miele Valentina Giorgio Maria Adele Alberelli Erica De Candia Antonio Gasbarrini Antonio Grieco
Publish Date: 2015/10/24
Volume: 17, Issue: 12, Pages: 120-
Abstract
Gut microbiota has been recently established to have a contributory role in the development of cardiometabolic disorders such as atherosclerosis obesity and type 2 diabetes Growing interest has focused on the modulation of gut microbiota as a therapeutic strategy in cardiovascular diseases and metabolic disorders In this paper we have reviewed the impact of gut microbiota on metabolic disorders and cardiovascular disease risk focusing on the newest findings in this field
Keywords: